Loading...
Price History
Market Data
| Market Cap | 16.92B |
| P/E Ratio | 12.57 |
| P/B Ratio | 4.01 |
| EPS | 15.48 |
| Dividend Yield | - |
| D/E Ratio | 4.91 |
| Current Ratio | 1.76 |
| Currency | USD |
Key Financial Metrics
21.31B
Revenue
2.37B
Net Income
15.48
EPS (Diluted)
4.56B
Free Cash Flow
Profitability
Gross Margin
-
Operating Margin
16.5%
Net Profit Margin
11.1%
EBITDA
4.37B
Returns & Efficiency
Return on Assets (ROA)
8.0%
Return on Equity (ROE)
56.1%
Dividend Yield
-
EPS
15.48
Financial Health
Total Assets
29.68B
Total Debt
13.09B
Debt to Equity
4.91x
Current Ratio
1.76
Insider Trading
Last 12 months
0
Buys
0
Sells
0
Insiders
Quick Access Filings
10-K
Annual Report
Loading...
10-Q
Quarterly Report
Loading...
8-K
Recent News
Loading...
Company Data Library
Earnings Transcripts
Loading...
Press Releases
Loading...
Filing Sections
Loading...
Company Info
| Industry | Health Services |
| HQ | DALLAS, TX |
| Fiscal Year | 2025 |
Peers
95.80B
P/E: --
95.80B
P/E: --
10.34B
P/E: --
1.90B
P/E: --
1.34B
P/E: --
ARDENT HEALTH, INC.
ARDT
1.34B
P/E: --
Ardent Health, Inc.
ARDT
1.34B
P/E: --
405.84M
P/E: --
Quick Links
Financial Statistics
Valuation
Market Cap$16.92B
P/E Ratio (TTM)12.6
Price to Book4.01
EV/Revenue-
EV/EBITDA-
Profitability
Gross Margin-
Operating Margin16.5%
Net Margin11.1%
ROE56.1%
ROA8.0%
Leverage & Liquidity
Debt to Equity4.91
Current Ratio1.76
Total Debt$13.09B
Total Assets$29.68B
Stockholders' Equity$4.22B
Income Statement (FY 2025)
Revenue$21.31B
Gross Profit-
Operating Income$3.51B
Net Income$2.37B
EPS (Diluted)$15.48
Cash Flow (FY 2025)
Free Cash Flow$4.56B
Cash & Equivalents$2.88B
Revenue Growth3.1%
SEC Filings by Category
Insider Trading Activity
Neutral
0 Buys $0
0 Sales $0
0 Exercises $0
Net: $0
| Insider | Title | Date | Type | Shares | Price | Value |
|---|
Company Information
| Business Address | 14201 DALLAS PARKWAY DALLAS, TX 75254 |
| Phone | 469-893-2200 |
| Incorporated | NV, US |
| EIN | 952557091 |
| Fiscal Year End | 1231 |
| Shares Outstanding | 86.96M |
| Stockholders' Equity | $4.22B |
| Cash & Equivalents | $2.88B |
Recent Filings
View All
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-04-30
Local
SCHEDULE 13G
Passive Ownership Report
Schedule 13G - passive beneficial ownership
Filed: 2026-04-30
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2026-04-30
Local
ARS
Annual Report to Shareholders
Annual report furnished to shareholders
Filed: 2026-04-16
Local
DEFA14A
Additional Proxy Materials
Additional definitive proxy soliciting materials
Filed: 2026-04-16
Local
DEF 14A
Definitive Proxy Statement
Official proxy statement for shareholder voting
Filed: 2026-04-16
Local
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-03-30
Local
144
Proposed Sale Notice
Notice of proposed sale of securities
Filed: 2026-03-11
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-10
Local
3
Initial Ownership Report
Initial statement of beneficial ownership of securities
Filed: 2026-03-09
Local
144
Proposed Sale Notice
Notice of proposed sale of securities
Filed: 2026-03-09
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-03
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-03
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-03
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-03
Local
Loading...
Loading management data...
Loading...
Loading board of directors...
Loading...
Loading institutional holders...
Loading...
Loading short interest data...
Financial Charts Annual (10-K)
Interactive financial visualizations
Show:
Revenue & Income Trends
Revenue & Profit
Profit Margins
Balance Sheet Breakdown
Assets Composition
Capital Structure
Cash Flow Analysis
Cash Flow Components
Free Cash Flow
Growth & Performance
Revenue Growth Rate (YoY %)
Key Ratio Trends
Company Profile
General Information
| Company Name | TENET HEALTHCARE CORP |
| Ticker | THC |
| Exchange | -- |
| Sector | Services |
| Industry | Health Services |
| Headquarters | DALLAS, TX |
| Fiscal Year | 2025 |
Financial Summary
| Market Cap | 16.92B |
| Revenue | 21.31B |
| Net Income | 2.37B |
| P/E Ratio | 12.57 |
| EPS | 15.48 |
| Net Margin | 11.1% |
| ROE | 56.1% |
| Dividend Yield | - |
Insider Transactions
Loading...
My Notes & Files
Personal Notes
Attached Files
Loading...